<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p69" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_69{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_69{left:341px;bottom:30px;}
#t3_69{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_69{left:377px;bottom:30px;}
#t5_69{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_69{left:540px;bottom:30px;}
#t7_69{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_69{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_69{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_69{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_69{left:285px;bottom:827px;letter-spacing:-0.32px;word-spacing:-0.15px;}
#tc_69{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_69{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_69{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_69{left:1123px;bottom:28px;letter-spacing:0.02px;}
#tg_69{left:36px;bottom:778px;letter-spacing:0.46px;}
#th_69{left:592px;bottom:778px;letter-spacing:0.36px;word-spacing:-0.32px;}
#ti_69{left:36px;bottom:447px;letter-spacing:-0.1px;}
#tj_69{left:36px;bottom:428px;letter-spacing:-0.08px;}
#tk_69{left:36px;bottom:410px;letter-spacing:-0.1px;}
#tl_69{left:98px;bottom:417px;}
#tm_69{left:188px;bottom:643px;letter-spacing:-0.09px;}
#tn_69{left:188px;bottom:625px;letter-spacing:-0.09px;}
#to_69{left:188px;bottom:607px;letter-spacing:-0.08px;}
#tp_69{left:188px;bottom:588px;letter-spacing:-0.1px;}
#tq_69{left:188px;bottom:570px;letter-spacing:-0.1px;}
#tr_69{left:188px;bottom:552px;letter-spacing:-0.09px;}
#ts_69{left:188px;bottom:409px;letter-spacing:-0.1px;}
#tt_69{left:188px;bottom:391px;letter-spacing:-0.09px;}
#tu_69{left:188px;bottom:372px;letter-spacing:-0.19px;word-spacing:0.1px;}
#tv_69{left:188px;bottom:354px;letter-spacing:-0.08px;}
#tw_69{left:188px;bottom:336px;letter-spacing:-0.09px;}
#tx_69{left:188px;bottom:317px;letter-spacing:-0.09px;}
#ty_69{left:188px;bottom:266px;letter-spacing:-0.08px;}
#tz_69{left:188px;bottom:248px;letter-spacing:-0.11px;}
#t10_69{left:280px;bottom:255px;}
#t11_69{left:374px;bottom:256px;letter-spacing:-0.25px;}
#t12_69{left:374px;bottom:403px;letter-spacing:-0.1px;}
#t13_69{left:374px;bottom:321px;letter-spacing:-0.1px;}
#t14_69{left:592px;bottom:412px;letter-spacing:-0.1px;}
#t15_69{left:655px;bottom:420px;}
#t16_69{left:668px;bottom:412px;letter-spacing:-0.09px;}
#t17_69{left:895px;bottom:420px;letter-spacing:-0.1px;}
#t18_69{left:916px;bottom:412px;letter-spacing:-0.19px;word-spacing:0.09px;}
#t19_69{left:1104px;bottom:420px;letter-spacing:-0.12px;}
#t1a_69{left:592px;bottom:394px;letter-spacing:-0.08px;}
#t1b_69{left:592px;bottom:357px;letter-spacing:-0.09px;}
#t1c_69{left:695px;bottom:365px;}
#t1d_69{left:708px;bottom:357px;letter-spacing:-0.17px;word-spacing:0.08px;}
#t1e_69{left:863px;bottom:365px;}
#t1f_69{left:871px;bottom:357px;letter-spacing:-0.08px;}
#t1g_69{left:592px;bottom:339px;letter-spacing:-0.06px;}
#t1h_69{left:592px;bottom:321px;letter-spacing:-0.33px;}
#t1i_69{left:646px;bottom:321px;letter-spacing:-0.1px;}
#t1j_69{left:810px;bottom:328px;}
#t1k_69{left:592px;bottom:302px;letter-spacing:-0.06px;}
#t1l_69{left:592px;bottom:284px;letter-spacing:-0.1px;}
#t1m_69{left:374px;bottom:630px;letter-spacing:-0.1px;}
#t1n_69{left:374px;bottom:464px;letter-spacing:-0.1px;}
#t1o_69{left:592px;bottom:474px;letter-spacing:-0.18px;word-spacing:-0.12px;}
#t1p_69{left:592px;bottom:456px;letter-spacing:-0.14px;word-spacing:0.04px;}
#t1q_69{left:592px;bottom:630px;letter-spacing:-0.1px;}
#t1r_69{left:592px;bottom:712px;letter-spacing:-0.1px;}
#t1s_69{left:655px;bottom:719px;}
#t1t_69{left:592px;bottom:580px;letter-spacing:-0.1px;}
#t1u_69{left:851px;bottom:588px;letter-spacing:-0.11px;}
#t1v_69{left:592px;bottom:562px;letter-spacing:-0.1px;}
#t1w_69{left:592px;bottom:543px;letter-spacing:-0.1px;}
#t1x_69{left:836px;bottom:551px;}
#t1y_69{left:592px;bottom:525px;letter-spacing:-0.1px;}
#t1z_69{left:823px;bottom:533px;}
#t20_69{left:836px;bottom:525px;letter-spacing:-0.06px;}
#t21_69{left:592px;bottom:507px;letter-spacing:-0.1px;}
#t22_69{left:756px;bottom:514px;letter-spacing:-0.12px;}
#t23_69{left:684px;bottom:754px;letter-spacing:-0.1px;}
#t24_69{left:684px;bottom:735px;letter-spacing:-0.09px;}
#t25_69{left:684px;bottom:717px;letter-spacing:-0.09px;}
#t26_69{left:750px;bottom:725px;}
#t27_69{left:681px;bottom:666px;letter-spacing:-0.1px;}
#t28_69{left:681px;bottom:648px;letter-spacing:-0.09px;}
#t29_69{left:681px;bottom:630px;letter-spacing:-0.09px;}
#t2a_69{left:747px;bottom:637px;}
#t2b_69{left:803px;bottom:744px;letter-spacing:-0.1px;}
#t2c_69{left:966px;bottom:753px;letter-spacing:-0.1px;}
#t2d_69{left:966px;bottom:734px;letter-spacing:-0.09px;}
#t2e_69{left:803px;bottom:716px;letter-spacing:-0.09px;}
#t2f_69{left:803px;bottom:698px;letter-spacing:-0.09px;word-spacing:-0.07px;}
#t2g_69{left:803px;bottom:680px;letter-spacing:-0.1px;}
#t2h_69{left:966px;bottom:706px;letter-spacing:-0.1px;}
#t2i_69{left:1132px;bottom:714px;letter-spacing:-0.12px;}
#t2j_69{left:966px;bottom:688px;letter-spacing:-0.09px;}
#t2k_69{left:806px;bottom:627px;letter-spacing:-0.08px;}
#t2l_69{left:806px;bottom:609px;letter-spacing:-0.09px;}
#t2m_69{left:966px;bottom:647px;letter-spacing:-0.13px;}
#t2n_69{left:989px;bottom:655px;}
#t2o_69{left:966px;bottom:629px;letter-spacing:-0.06px;}
#t2p_69{left:966px;bottom:611px;letter-spacing:-0.1px;}
#t2q_69{left:966px;bottom:592px;letter-spacing:-0.1px;}
#t2r_69{left:1054px;bottom:600px;letter-spacing:-0.12px;}
#t2s_69{left:966px;bottom:548px;letter-spacing:-0.09px;}
#t2t_69{left:966px;bottom:530px;letter-spacing:-0.09px;}
#t2u_69{left:632px;bottom:252px;}
#t2v_69{left:642px;bottom:246px;letter-spacing:0.12px;}
#t2w_69{left:640px;bottom:231px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2x_69{left:640px;bottom:215px;letter-spacing:0.12px;}
#t2y_69{left:925px;bottom:215px;letter-spacing:0.13px;}
#t2z_69{left:1009px;bottom:215px;}
#t30_69{left:632px;bottom:206px;}
#t31_69{left:642px;bottom:200px;letter-spacing:0.11px;word-spacing:0.02px;}
#t32_69{left:640px;bottom:185px;letter-spacing:0.12px;}
#t33_69{left:640px;bottom:170px;letter-spacing:0.12px;}
#t34_69{left:632px;bottom:160px;}
#t35_69{left:638px;bottom:154px;letter-spacing:0.09px;word-spacing:0.02px;}
#t36_69{left:640px;bottom:139px;letter-spacing:0.13px;}
#t37_69{left:632px;bottom:130px;}
#t38_69{left:638px;bottom:124px;letter-spacing:0.13px;word-spacing:-0.04px;}
#t39_69{left:640px;bottom:108px;letter-spacing:0.01px;}
#t3a_69{left:709px;bottom:108px;letter-spacing:0.08px;}
#t3b_69{left:727px;bottom:108px;letter-spacing:0.14px;word-spacing:-0.06px;}
#t3c_69{left:1121px;bottom:108px;}
#t3d_69{left:36px;bottom:221px;}
#t3e_69{left:46px;bottom:215px;letter-spacing:0.12px;word-spacing:-0.03px;}
#t3f_69{left:557px;bottom:215px;}
#t3g_69{left:36px;bottom:206px;}
#t3h_69{left:46px;bottom:200px;letter-spacing:0.1px;word-spacing:-0.04px;}
#t3i_69{left:319px;bottom:200px;}
#t3j_69{left:36px;bottom:191px;}
#t3k_69{left:46px;bottom:185px;letter-spacing:0.1px;}
#t3l_69{left:45px;bottom:170px;letter-spacing:0.08px;}
#t3m_69{left:67px;bottom:170px;letter-spacing:0.12px;word-spacing:-0.02px;}
#t3n_69{left:609px;bottom:170px;}
#t3o_69{left:36px;bottom:160px;}
#t3p_69{left:46px;bottom:154px;letter-spacing:0.13px;}
#t3q_69{left:261px;bottom:154px;}
#t3r_69{left:36px;bottom:145px;}
#t3s_69{left:46px;bottom:139px;letter-spacing:0.13px;}
#t3t_69{left:45px;bottom:124px;letter-spacing:0.1px;}
#t3u_69{left:36px;bottom:114px;}
#t3v_69{left:43px;bottom:108px;letter-spacing:0.11px;word-spacing:0.01px;}
#t3w_69{left:499px;bottom:108px;letter-spacing:0.15px;}
#t3x_69{left:557px;bottom:108px;}
#t3y_69{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_69{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_69{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_69{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_69{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_69{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_69{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_69{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s7_69{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.s8_69{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s9_69{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sa_69{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.sb_69{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts69" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg69Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg69" style="-webkit-user-select: none;"><object width="1210" height="935" data="69/69.svg" type="image/svg+xml" id="pdf69" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_69" class="t s0_69">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_69" class="t s1_69">® </span>
<span id="t3_69" class="t s0_69">(NCCN </span>
<span id="t4_69" class="t s1_69">® </span>
<span id="t5_69" class="t s0_69">), All rights reserved. NCCN Guidelines </span>
<span id="t6_69" class="t s1_69">® </span>
<span id="t7_69" class="t s0_69">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_69" class="t s2_69">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_69" class="t s2_69">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_69" class="t s3_69">NCCN Guidelines Version 4.2024 </span>
<span id="tb_69" class="t s3_69">Very Advanced Head and Neck Cancer </span>
<span id="tc_69" class="t s4_69">NCCN Guidelines Index </span>
<span id="td_69" class="t s4_69">Table of Contents </span>
<span id="te_69" class="t s4_69">Discussion </span>
<span id="tf_69" class="t s5_69">ADV-3 </span>
<span id="tg_69" class="t s5_69">DIAGNOSIS </span><span id="th_69" class="t s5_69">TREATMENT OF HEAD AND NECK CANCER </span>
<span id="ti_69" class="t s5_69">Recurrent </span>
<span id="tj_69" class="t s5_69">or persistent </span>
<span id="tk_69" class="t s5_69">disease </span>
<span id="tl_69" class="t s6_69">e </span>
<span id="tm_69" class="t s5_69">Locoregional </span>
<span id="tn_69" class="t s5_69">recurrence </span>
<span id="to_69" class="t s5_69">or persistent </span>
<span id="tp_69" class="t s5_69">disease </span>
<span id="tq_69" class="t s5_69">without </span>
<span id="tr_69" class="t s5_69">prior RT </span>
<span id="ts_69" class="t s5_69">Locoregional </span>
<span id="tt_69" class="t s5_69">recurrence, </span>
<span id="tu_69" class="t s5_69">second primary, </span>
<span id="tv_69" class="t s5_69">or persistent </span>
<span id="tw_69" class="t s5_69">disease with </span>
<span id="tx_69" class="t s5_69">prior RT </span>
<span id="ty_69" class="t s5_69">Distant </span>
<span id="tz_69" class="t s5_69">metastases </span>
<span id="t10_69" class="t s6_69">f </span>
<span id="t11_69" class="t s7_69">(ADV-4) </span>
<span id="t12_69" class="t s5_69">Resectable </span>
<span id="t13_69" class="t s5_69">Unresectable </span>
<span id="t14_69" class="t s5_69">Surgery </span>
<span id="t15_69" class="t s6_69">d </span>
<span id="t16_69" class="t s5_69">± postoperative reirradiation </span>
<span id="t17_69" class="t s6_69">b,i </span>
<span id="t18_69" class="t s5_69">or systemic therapy/RT, </span>
<span id="t19_69" class="t s6_69">a,b </span>
<span id="t1a_69" class="t s5_69">clinical trial preferred </span>
<span id="t1b_69" class="t s5_69">Reirradiation </span>
<span id="t1c_69" class="t s6_69">b </span>
<span id="t1d_69" class="t s5_69">± systemic therapy, </span>
<span id="t1e_69" class="t s6_69">j </span>
<span id="t1f_69" class="t s5_69">clinical trial preferred </span>
<span id="t1g_69" class="t s5_69">or </span>
<span id="t1h_69" class="t s7_69">ADV-4 </span><span id="t1i_69" class="t s5_69">for systemic therapy </span>
<span id="t1j_69" class="t s6_69">j </span>
<span id="t1k_69" class="t s5_69">or </span>
<span id="t1l_69" class="t s5_69">Best supportive care </span>
<span id="t1m_69" class="t s5_69">Resectable </span>
<span id="t1n_69" class="t s5_69">Unresectable </span>
<span id="t1o_69" class="t s7_69">Treatment of Very Advanced </span>
<span id="t1p_69" class="t s7_69">Head and Neck Cancer (ADV-1) </span>
<span id="t1q_69" class="t s5_69">or </span>
<span id="t1r_69" class="t s5_69">Surgery </span>
<span id="t1s_69" class="t s6_69">d </span>
<span id="t1t_69" class="t s5_69">Concurrent systemic therapy/RT </span>
<span id="t1u_69" class="t s6_69">a,b,c </span>
<span id="t1v_69" class="t s5_69">or </span>
<span id="t1w_69" class="t s5_69">Combination systemic therapy </span>
<span id="t1x_69" class="t s6_69">a </span>
<span id="t1y_69" class="t s5_69">(category 2B) followed by RT </span>
<span id="t1z_69" class="t s6_69">b </span>
<span id="t20_69" class="t s5_69">or </span>
<span id="t21_69" class="t s5_69">systemic therapy/RT </span>
<span id="t22_69" class="t s6_69">a,b,h </span>
<span id="t23_69" class="t s5_69">No adverse </span>
<span id="t24_69" class="t s5_69">pathologic </span>
<span id="t25_69" class="t s5_69">features </span>
<span id="t26_69" class="t s6_69">g </span>
<span id="t27_69" class="t s5_69">Adverse </span>
<span id="t28_69" class="t s5_69">pathologic </span>
<span id="t29_69" class="t s5_69">features </span>
<span id="t2a_69" class="t s6_69">g </span>
<span id="t2b_69" class="t s5_69">Observation </span>
<span id="t2c_69" class="t s5_69">Follow-up </span>
<span id="t2d_69" class="t s7_69">(FOLL-A, 1 of 2) </span>
<span id="t2e_69" class="t s5_69">Extranodal </span>
<span id="t2f_69" class="t s5_69">extension and/or </span>
<span id="t2g_69" class="t s5_69">positive margin </span>
<span id="t2h_69" class="t s5_69">Systemic therapy/RT </span>
<span id="t2i_69" class="t s6_69">a,b </span>
<span id="t2j_69" class="t s5_69">(category 1) </span>
<span id="t2k_69" class="t s5_69">Other risk </span>
<span id="t2l_69" class="t s5_69">features </span>
<span id="t2m_69" class="t s5_69">RT </span>
<span id="t2n_69" class="t s6_69">b </span>
<span id="t2o_69" class="t s5_69">or </span>
<span id="t2p_69" class="t s5_69">Consider systemic </span>
<span id="t2q_69" class="t s5_69">therapy/RT </span>
<span id="t2r_69" class="t s6_69">a,b </span>
<span id="t2s_69" class="t s5_69">Therapy for persistent </span>
<span id="t2t_69" class="t s5_69">disease as indicated </span>
<span id="t2u_69" class="t s8_69">g </span>
<span id="t2v_69" class="t s9_69">Adverse pathologic features: extranodal extension, positive margins, close </span>
<span id="t2w_69" class="t s9_69">margins, pT3 or pT4 primary, pN2 or pN3 nodal disease, perineural invasion, </span>
<span id="t2x_69" class="t s9_69">vascular invasion, and lymphatic invasion </span><span id="t2y_69" class="t sa_69">(Discussion)</span><span id="t2z_69" class="t s9_69">. </span>
<span id="t30_69" class="t s8_69">h </span>
<span id="t31_69" class="t s9_69">Combination systemic therapy followed by RT or systemic therapy/RT may be </span>
<span id="t32_69" class="t s9_69">considered for cytoreduction or symptom control followed by local therapy as </span>
<span id="t33_69" class="t s9_69">indicated. </span>
<span id="t34_69" class="t s8_69">i </span>
<span id="t35_69" class="t s9_69">Reirradiation should be limited to a highly select subset of patients (Janot F, et </span>
<span id="t36_69" class="t s9_69">al. J Clin Oncol 2008;26:5518-5523). </span>
<span id="t37_69" class="t s8_69">j </span>
<span id="t38_69" class="t sa_69">See Principles of Systemic Therapy for Non-Nasopharyngeal Cancers </span>
<span id="t39_69" class="t sa_69">(SYST-A) </span><span id="t3a_69" class="t s9_69">or </span><span id="t3b_69" class="t sa_69">Systemic Therapy for Nasopharyngeal Cancers (NASO-B)</span><span id="t3c_69" class="t s9_69">. </span>
<span id="t3d_69" class="t s8_69">a </span>
<span id="t3e_69" class="t sa_69">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t3f_69" class="t s9_69">. </span>
<span id="t3g_69" class="t s8_69">b </span>
<span id="t3h_69" class="t sa_69">Principles of Radiation Therapy (ADV-A)</span><span id="t3i_69" class="t s9_69">. </span>
<span id="t3j_69" class="t s8_69">c </span>
<span id="t3k_69" class="t s9_69">When using concurrent systemic therapy/RT, the preferred agent is cisplatin (category </span>
<span id="t3l_69" class="t s9_69">1). </span><span id="t3m_69" class="t sa_69">See Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t3n_69" class="t s9_69">. </span>
<span id="t3o_69" class="t s8_69">d </span>
<span id="t3p_69" class="t sa_69">Principles of Surgery (SURG-A)</span><span id="t3q_69" class="t s9_69">. </span>
<span id="t3r_69" class="t s8_69">e </span>
<span id="t3s_69" class="t s9_69">Consider next-generation sequencing (NGS) genomic profiling for biomarker </span>
<span id="t3t_69" class="t s9_69">identification. </span>
<span id="t3u_69" class="t s8_69">f </span>
<span id="t3v_69" class="t s9_69">Consider palliative RT as clinically indicated (eg, bone metastases) </span><span id="t3w_69" class="t sa_69">(RAD-A)</span><span id="t3x_69" class="t s9_69">. </span>
<span id="t3y_69" class="t sb_69">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
